Trial NCT00438204

View at ClinicalTrials.gov 
Org. Study IDs: CDR0000531832
Secondary IDs: P30CA022453 WSU-036806MP4F WSU-2005-008

Last trial update was posted on 2021-04-13

MeSH Interventions

Bevacizumab Gemcitabine Pemetrexed

MeSH Conditions

Carcinoma, Non-Small-Cell Lung Lung Neoplasms

Other Conditions

Lung Cancer

Stopping Reasons

All data collection has completed.

Limitations And Caveats

There were no significant limitations of the trial.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID